From my perspective, the Open lab has been a process of mutual learning. Scientists from the Tuberculosis field have come and shared ideas and new ways of doing things. We have helped maturing and incubating their projects. Specially, giving our specialized support for speeding up the drug discovery process. Definitively building up bridges to come up with new ideas and future collaborations.

The Open Lab is an enriching initiative that fosters collaboration among scientists worldwide. It has provided a unique opportunity to bring diverse perspectives together, advancing efforts to eradicate malaria and laying the foundation for future projects. Through my experience, I’ve witnessed how this program drives innovation, mutual learning, and impactful partnerships. Working alongside brilliant minds has been a rewarding journey that reinforces the power of global collaboration to address pressing health challenges.

The Open Lab experience has been profoundly enriching, fostering connections with leading groups in the tuberculosis field. Their innovative ideas, combined with our expertise, have created a powerful synergy that drives impactful projects in drug discovery. Together, we are pushing the boundaries of science and innovation to achieve new heights.

The Tres Cantos Open Lab (TCOLF) program exemplifies the power of collaboration in driving progress against global health challenges. Through TCOLF, I have had the privilege of supporting the development of the protocol for a clinical trial that emerged from an initial fellowship and discovery project. The trial holds significant promise in addressing the treatment of a neglected tropical disease, showcasing the TCOLF program's ability to translate innovative research into tangible impact. The Open Lab’s collaborative approach has been instrumental in fostering partnerships, advancing science, and reinforcing GSK’s commitment to getting ahead of infectious diseases together.